SEC Form 4 · accession 0001209191-17-048572
BioAmber Inc. · BIOA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mario Settino
Officer — Chief Financial Officer
Period of report
Aug 9, 2017
Accepted (ET)
Aug 11, 2017 · 3:06 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001534287
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Aug 9, 2017 | P | 15,000 | $0.5349 | A | 30,000 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The price reported represents the weighted average sale price of the shares acquired. The prices of the shares acquired in the reported transaction ranged from $0.53 to $0.535 per share. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer or a security holder of the Issuer, to provide full information regarding the number of shares purchased at each separate price.